Luca De Luca
Luca De Luca publishes mostly in Surgery, Pulmonary and Respiratory Medicine and Oncology, on topics such as Gallbladder and Bile Duct Disorders, Esophageal and GI Pathology and Pancreatic and Hepatic Oncology Research.
- World rank
- #3,045,272 of 7,710,434 ranked researchers
- Rank in Italy
- #102,909 of 242,206
- Works
- 77
- Citations
- 1.1k
- Citations per work
- 14.0
What does Luca De Luca research?
Luca De Luca's work is mostly in Medicine (72%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5571.9%
- Medicine5571.9%
- Everything else1924.5%
- Life Sciences33.6%
- 1Surgery26% of their works
- 2Pulmonary and Respiratory Medicine20% of their works
- 3Oncology18% of their works
- 4Gastroenterology6% of their works
- 5Molecular Biology4% of their works
- 6Hepatology2% of their works
Research topics
- Gallbladder and Bile Duct Disorders
- Esophageal and GI Pathology
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Screening and Detection
- Gastric Cancer Management and Outcomes
- Helicobacter pylori-related gastroenterology studies
- Esophageal Cancer Research and Treatment
- Gastrointestinal Tumor Research and Treatment
Which keywords describe Luca De Luca's research?
The keywords of their largest research topics: Chemotherapy, Neoadjuvant Therapy, Gastric Cancer, Prevention, Endoscopic Resection, Cholecystitis, ERCP and Endoscopic Stenting.
- Imatinib Mesylate
- Esophageal Carcinoma
- Helicobacter pylori
- Molecular Characterization
- Colorectal Cancer
- Pancreatic Cancer
- Endoscopic Stenting
- Cholecystitis
- Prevention
- Neoadjuvant Therapy
- Chemotherapy
- Gastric Cancer
- Endoscopic Resection
- ERCP
- Esophageal Perforation
- Surgical Complications
- Lymph Node Dissection
- Screening
- Inflammation
- Preoperative Chemoradiotherapy
- Sunitinib
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Chemotherapy272 topics
- Neoadjuvant Therapy242 topics
- Gastric Cancer222 topics
- Prevention222 topics
- Endoscopic Resection212 topics
- Cholecystitis191 topic
- ERCP191 topic
- Endoscopic Stenting181 topic
- Esophageal Perforation181 topic
- Pancreatic Cancer151 topic
- Surgical Complications151 topic
- Colorectal Cancer121 topic
- Lymph Node Dissection121 topic
- Molecular Characterization121 topic
- Screening121 topic
- Helicobacter pylori101 topic
- Inflammation101 topic
- Esophageal Carcinoma91 topic
- Preoperative Chemoradiotherapy91 topic
- Imatinib Mesylate51 topic
- Sunitinib51 topic
Where does Luca De Luca work?
Luca De Luca's main affiliation in the publication record is Ospedali Riuniti Marche Nord, Italy.
How many publications and citations does Luca De Luca have?
OpenAlex counts 77 works and 1,078 citations for Luca De Luca, an h-index of 19, ranking #3,045,272 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Luca De Luca. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.